- State of protection against polio in children, who receive immunosuppressive therapy
State of protection against polio in children, who receive immunosuppressive therapy
Modern Pediatrics.Ukraine.2020.3(107):29-32; doi 10.15574/SP.2020.107.29
Lisovska A. M., Volokha A. P., Bondarenko A. V., Marushko T. V., Golubovskaya Yu. E.
Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
For citation: Lisovska AM, Volokha AP, Bondarenko AV, Marushko TV, Golubovskaya YuE. (2020). State of protection against polio in children, who receive immunosuppressive therapy. Modern Pediatrics. Ukraine. 3(107): 29–32; doi 10.15574/SP.2020.107.29
Article received: Dec 14, 2019. Accepted for publication: Apr 16, 2020.
Objective: to examine the state of protection from polio in a previously vaccinated patients receiving immunosuppressive therapy.
Materials and methods. The object of the study were children with rheumatic and nephrological diseases, receiving immunosuppressive therapy. Laboratory evaluation of immune protection against polio was carried out in two groups: the main was 24 children, who were on immunosuppressive therapy, control — 25 healthy vaccinated children.
Results. Significant difference between the average level of antibodies to the polio of the main group and control group not identified (p=0.589). Protected against polio were 70.8%, who receive immunosuppressive therapy compared to 60% of the children in the control group.
Conclusions. The data obtained on post-vaccination immunity against polio in a previously vaccinated children in Ukraine on the background of immunosuppressive therapy indicate its adequate level in a timely vaccination.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of an participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interest was declared by the authors.
Key words: immunosuppressive therapy, vaccination, children, specific antibodies to poliovirus.
1. Volokha AP. (2014). Vaktsynatsiia hrup ryzyku. Zdorov'ye rebenka. 3(54):160–166. http://www.mif-ua.com/archive/article/38733
2. Kramarov SO, Palatna LO, Lysyi AV. (2016). Poliomiyelit v svitita Ukrayini: problema chy ni? Klinichna imunolohiya. Alerholohiya. Infektolohiya. 4(93): 10–17. https://kiai.com.ua/ua-issue-article01291/Poliomiielit-v-sviti-ta-Ukrayini-problema-amp-nbsp-chi-amp-nbsp-ni
3. Romanyshyn I, Kostyuchenko L, Boyko I. (2014). Suchasni aspekty vaktsynatsiyi ditey iz revmatychnymy zakhvoryuvannyamy (ohlyad literatury). Bykovyns'kyy medychnyy visnyk. 4(72):222–226. http://www.irbis-nbuv.gov.ua/cgi-bin/irbis_nbuv/cgiirbis_64.exe?I21DBN=LINK&P21DBN=UJRN&Z21ID=&S21REF=10&S21CR=20&S21STN=1&S21FMT=ASP_meta&C21COM=S&2_S21P03=FILA=&2_S21STR=bumv_2014_18_4_57
5. Tsyganchuk OM. (2017). Poliomyelitis: new challenges on the way to eradication. Sovremennaya pediatriya. 3(83): 27–37. https://doi.org/10.15574/SP.2017.83.27
6. Chernyshova LI, Lapiy FI, Volokha AP (redaktory). (2019). Imunoprofilaktyka infektsiynykh khvorob. 20e vyd., pererob. Kyiv: VSV Medytsyna.